Low-level arsenic exposure in drinking water and bladder cancer: A review and meta-analysis

Regulatory Toxicology and Pharmacology

Volumn 52, Issue 3, 2008, Pages 299-310

  Mink, Pamela J ^a   Alexander, Dominik D ^a   Barraj, Leila M ^a   Kelsh, Michael A ^a   Tsuji, Joyce S ^a  

^a EXPONENT INC   (United States)

Author keywords

Arsenic; Bladder cancer risk; Drinking water; Meta analysis

Indexed keywords

ARSENIC; DRINKING WATER;

ACCURACY; ARTICLE; BLADDER CANCER; CANCER RISK; ENVIRONMENTAL EXPOSURE; HUMAN; PRIORITY JOURNAL; SMOKING;

ARSENIC; ARSENIC POISONING; CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; HUMANS; RISK ASSESSMENT; URINARY BLADDER NEOPLASMS; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 56249138227     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2008.08.010     Document Type: Article

References (52)

1. Andersson, T, Ahlbom, A., 2003. Meta-analysis. In: Rothman, K., (Ed.), Episheet Software; Spreadsheets for the Analysis of Epidemiological Data. Available from: members.aol.com/krothman/episheet.xls.
2. Ayotte J.D., Baris D., Cantor K.P., Colt J., Robinson Jr. G.R., Lubin J.H., Karagas M., Hoover R.N., Fraumeni Jr. J.F., and Silverman D.T. Bladder cancer mortality and private well use in New England: an ecological study. J. Epidemiol. Community Health 60 (2006) 168-172
3. Baastrup R., Sørensen M., Balstrøm T., Frederiksen K., Larsen C.L., Tjønneland A., Overvad K., and Raaschou-Nielsen O. Arsenic in drinking-water and risk for cancer in Denmark. Environ. Health Perspect. 116 2 (2008) 231-237
4. Bates M.N., Smith A.H., and Cantor K.P. Case-control study of bladder cancer and arsenic in drinking water. Am. J. Epidemiol. 141 6 (1995) 523-530
5. Bates M.N., Rey O.A., Biggs M.L., Hopenhayn C., Moore L.E., Kalman D., Steinmaus C., and Smith A.H. Case-control study of bladder cancer and exposure to arsenic in Argentina. Am. J. Epidemiol. 159 4 (2004) 381-389
6. Berg J.W., and Burbank F. Correlations between carcinogenic trace metals in water supplies and cancer mortality. Ann. NY Acad. Sci. 199 (1972) 249-264
7. Brown K.G. How creditable are cancer risk estimates from the SW Taiwan database for arsenic in drinking water?. Hum. Ecol. Risk Assess. 13 (2007) 190
8. Brown K.G., and Ross G.L. Arsenic, drinking water, and health: aA position paper of the American Council on Science and Health. Regul. Toxicol. Pharmacol. 36 2 (2002) 162-174
9. Cantor K.P., and Lubin J.H. Arsenic, internal cancers, and issues in inference from studies of low-level exposures in human populations. Toxicol. Appl. Pharmacol. 222 3 (2007) 252-257
10. Checkoway H., Pearce N.E., and Kriebel D. Research Methods in Occupational Epidemiology. second ed (2004), Oxford University Press, New York
11. Chen C.J., Chuang Y.C., Lin T.M., and Wu H.Y. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 45 11 Pt. 2 (1985) 5895-5899
12. Chen C.J., Chen C.W., Wu M.M., and Kuo T.L. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer 66 5 (1992) 888-892
13. Chen, C.-J., Hsueh, Y.-M., Tseng, M.-P., Lin, Y.-C., Hsu, L.-I., Chou, W.-L., Chiou, H.-Y., Wang, I.-H., Chou, Y.-L., Tseng, C.-H., Liou, S.-H., 2001. Individual susceptibility to arseniasis. In: Chappell, W.R., Abernathy, C.O., Calderon, R.L. (Eds.) Proceedings of the Fourth Annual International Conference on Arsenic Exposure and Health Effects, June 18-22, 2000. Elsevier Science Ltd., pp. 135-143.
14. Chiou H.-Y., Hsueh Y.-M., Liaw K.-F., Horng S.-F., Chiang M.-H., Pu Y.-S., Lin J.S.-N., Huang C.-H., and Chen C.-J. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 55 6 (1995) 1296-1300
15. Chiou H.-Y., Chiou S.-T., Hsu Y.-H., Chou Y.-L., Tseng C.-H., Wei M.-L., and Chen C.-J. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8, 102 residents in an arseniasis-endemic area in northeastern Taiwan. Am. J. Epidemiol. 153 5 (2001) 411-418
16. Chu H.A., and Crawford-Brown D.J. Inorganic arsenic in drinking water and bladder cancer: a meta-analysis for dose-response assessment. Int. J. Environ. Res. Public Health 3 4 (2006) 316-322
17. Cohen S.M., Arnold L.L., Eldan M., Lewis A.S., and Beck B.D. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit. Rev. Toxicol. 36 2 (2006) 99-133
18. Gamble M.V., Liu X., Ahsan H., Pilsner J.R., Llievski V., Slavkovich V., Parvez F., Levy D., Factor-Litvak P., and Graziano J.H. Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ. Health Perspect. 113 12 (2005) 1683-1688
19. Gamble M.V., Liu X., Slakovich V., Pilsner J.R., Ilievski V., Factor-Litvak P., Levy D., Alam S., Islam M., Parvez F., Ahsan H., and Graziano J.H. Folic acid supplementation lowers blood arsenic. Am. J. Clin. Nutr. 86 (2007) 1202-1209
20. Garland M., Morris J.S., Rosner B.A., Stampfer M.J., Spate V.L., Baskett C.J., Willett W.C., and Hunter D.J. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol. Biomarkers Prev. 2 (1993) 493-497
21. Greenland S. Meta-analysis. In: Rothman K.J., and Greenland S. (Eds). Modern Epidemiology. second ed. (1998), Lippincott-Raven Publishers, Philadelphia, PA 643-673
22. Hedges L.V., and Pigott T.D. The power of statistical tests in meta-analysis. Psychol. Methods 6 3 (2001) 203-217
23. IARC, 1986. Tobacco smoking. IARC Monographs on the Evaluation of Carcinogenetic Risks to Humans, vol. 38. International Agency for Research on Cancer.
24. Infante-Rivard C., Olson E., Jacques L., and Ayotte P. Drinking water contaminants and childhood leukemia. Epidemiology 12 1 (2001) 13-19
25. Karagas M.R., Stukel T.A., and Tosteson T.D. Assessment of cancer risk and environmental levels of arsenic in New Hampshire. Int. J. Environ. Health 205 (2002) 85-94
26. Karagas M.R., Tosteson T.D., Blum J., Klaue B., Weiss J.E., Stannard V., Spate V., and Morris J.S. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am. J. Epidemiol. 152 1 (2000) 84-90
27. Karagas M.R., Tosteson T.D., Morris J.S., Demidenko E., Mott L.A., Heaney J., and Schned A. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 15 5 (2004) 465-472
28. Kogevinas M., and Trichopoulos D. Urinary bladder cancer. In: Adami H.O., Hunter D., and Trichopoulos D. (Eds). Textbook of Cancer Epidemiology (2002), Oxford University Press, New York 446-466
29. Kurttio P., Pukkala E., Kahelin H., Auvinen A., and Pekkanen J. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ. Health Perspect. 107 9 (1999) 705-710
30. Lamm S.H., and Kruse M.B. Arsenic ingestion and bladder cancer mortality: what do the dose-response relationships suggest about mechanism?. Hum. Ecol. Risk Assess. 11 2 (2005) 433-450
31. Lamm S.H., Byrd D.M., Kruse M.B., Feinleib M., and Lai S.H. Bladder cancer and arsenic exposure: differences in the two populations enrolled in a study in southwest Taiwan. Biomed. Environ. Sci. 16 4 (2003) 355-368
32. Lamm S.H., Engel A., Kruse M.B., Feinleib M., Byrd D.M., Lai S., and Wilson R. Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 US counties and 30 years of observation. J. Occup. Environ. Med. 46 3 (2004) 298-306
33. Lamm S.H., Engel A., Penn C.A., Chen R., and Feinleib M. Arsenic cancer risk confounder in southwest Taiwan data set. Environ. Health Perspect. 114 7 (2006) 1077-1082
34. Lewis D.R., Southwick J.W., Ouellet-Hellstrom R., Rench J., and Calderon R.L. Drinking water arsenic in Utah: a cohort mortality study. Environ. Health Perspect. 107 5 (1999) 359-365
35. Michaud D.S., Wright M.E., Cantor K.P., Taylor P.R., Virtamo J., and Albanes D. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers. Am. J. Epidemiol. 160 9 (2004) 853-859
36. Milton A.H., Hasan Z., Shahidullah S.M., Sharmin S., Jakariya M.D., Rahman M., Dear K., and Smith W. Association between nutritional status and arsenicosis due to chronic arsenic exposure in Bangladesh. Int. J. Environ. Health Res. 14 2 (2004) 99-108
37. Moore L.E., Lu M., and Smith A.H. Childhood cancer incidence and arsenic exposure in drinking water in Nevada. Arch. Environ. Health 57 3 (2002) 201-206
38. Moore L.E., Smith A.H., Eng C., DeVries S., Kalman D., Bhargava V., Chew K., Ferreccio C., Rey O.A., Hopenhayn C., Biggs M.L., Bates M.N., and Waldman F.M. P53 alterations in bladder tumors from arsenic and tobacco exposed patients. Carcinogenesis 24 11 (2003) 1785-1791
39. Morales K.H., Ryan L., Kuo T.L., Wu M.-M., and Chen C.-J. Risk of internal cancers from arsenic in drinking water. Environ. Health Perspect. 108 7 (2000) 655-661
40. Morton W., Starr G., Pohl D., Stoner J., Wagner S., and Weswig D. Skin cancer and water arsenic in Lane County, Oregon. Cancer 37 5 (1976) 2523-2532
41. NRC, 2001. Arsenic in drinking water: 2001 update. National Research Council, Washington, DC.
42. Rubin C.S., Holmes A.K., Belson M.G., Jones R.L., Flanders W.D., Kieszak S.M., Osterloh J., Luber G.E., Blount B.C., Barr D.B., Steinberg K.K., Satten G.A., McGeehin M.A., and Todd R.L. Investigating childhood leukemia in Churchill County, Nevada. Environ. Health Perspect. 115 1 (2007) 151-157
43. Schoen A., Beck B., Sharma R., and Dube E. Arsenic toxicity at low doses: epidemiological and mode of action considerations. Toxicol. Appl. Pharmacol. 198 3 (2004) 253-267
44. Snow E.T., Sykora P., Durham T.R., and Klein C.B. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?. Toxicol. Appl. Pharmacol. 207 2S (2005) 557-564
45. Steinberg K.K., Relling M.V., Gallagher M.L., Greene C.N., Rubin C.S., French D., Holmes A.K., Carroll W.L., Koontz D.A., Sampson E.J., and Satten G.A. Genetic studies of a cluster of acute lymphoblastic leukemia cases in Churchill County, Nevada. Environ. Health Perspect. 115 1 (2007) 158-164
46. Steinmaus C., Yuan Y., Bates M.N., and Smith A.H. Case-control study of bladder cancer and drinking water arsenic in the western United States. Am. J. Epidemiol. 158 12 (2003) 1193-1201
47. Tseng W.-P. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 19 (1977) 109-119
48. Tseng W.-P., Chu H.M., How S.W., Fong J.M., Lin C.S., and Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40 3 (1968) 453-463
49. US EPA, 1998. Integrated Risk Information System: Arsenic. Carcinogenicity Assessment Last Revised April 10, 1998. US Environmental Protection Agency. Available from: (accessed 06.05.08.).
50. US EPA, 2005. Guidelines for Carcinogen Risk Assessment. EPA/630/P-03/001F. US Environmental Protection Agency, Risk Assessment Forum, Washington, DC.
51. US EPA, 2008. Probabilistic Risk Assessment for Children who Contact CCA-Treated Playsets and Decks. Final Report. Prepared by J. Chen, N. Mottl, T. Lindheimer, N. Cook. US Environmental Protection Agency, Office of Pesticide Programs, Antimicrobials Division, Washington, DC.
52. Wu M.-M., Kuo T.-L., Hwang Y.-H., and Chen C.-J. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 130 6 (1989) 1123-1132